Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients

Abstract

Compared with the general population, HL survivors have a substantially reduced life expectancy. Optimal selection of patients for primary CT is crucial, weighing risks of HL relapse and long-term toxicity.